ARCHIVES

FDA Should Delay Provenge Decision Pending Definitive Trial Results, ODAC Chairman Writes.

This article is from The Cancer Letter archive.

Vol. 33 No. 16 | April 27, 2007

Download PDF Visit The Full Archive

Related Articles

Government Offers Two Approval Standards For Assays: CLIA, FDA

January 30, 2009

Pooled Analysis of 12 Seperate Yervoy Studies Shows Survival-Curve Plateau at 3 Years

October 25, 2013

CTEP Drafts FDA Approval Guidelines

March 4, 1988

RFA: Native American Women’s Cancer Initiative

July 9, 1993

NIH Drops Objections To Bill For Research On Environmental Causes of Breast Cancer.

May 23, 2008

Funding Opportunity: DOD Offering 10.5 Million For Lung Cancer Research

May 30, 2014